604 related articles for article (PubMed ID: 33998283)
1. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction.
Albar Z; Albakri M; Hajjari J; Karnib M; Janus SE; Al-Kindi SG
Am J Cardiol; 2022 Mar; 167():68-75. PubMed ID: 34986991
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
Bansal N; Zelnick LR; Scherzer R; Estrella M; Shlipak MG
Circ Heart Fail; 2024 May; 17(5):e011173. PubMed ID: 38742428
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
[TBL] [Abstract][Full Text] [Related]
9. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
10. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
[TBL] [Abstract][Full Text] [Related]
11. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
[TBL] [Abstract][Full Text] [Related]
13. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
de Boer RA; Nayor M; deFilippi CR; Enserro D; Bhambhani V; Kizer JR; Blaha MJ; Brouwers FP; Cushman M; Lima JAC; Bahrami H; van der Harst P; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Shah SJ; Levy D; Herrington DM; Larson MG; van Gilst WH; Gottdiener JS; Bertoni AG; Ho JE
JAMA Cardiol; 2018 Mar; 3(3):215-224. PubMed ID: 29322198
[TBL] [Abstract][Full Text] [Related]
14. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
15. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
[TBL] [Abstract][Full Text] [Related]
16. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.
Lyle MA; Iyer SR; Redfield MM; Reddy YNV; Felker GM; Cappola TP; Hernandez AF; Scott CG; Burnett JC; Pereira NL
JACC Heart Fail; 2020 Jan; 8(1):70-80. PubMed ID: 31392960
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
20. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
